Cardiovascular Stents Market Size, Share and Industry Analysis By Product Type (Coronary Stenting, Peripheral Stenting), Stent Type (Drug Eluting Stents (DES), Bioresorbable Stents, Bare Metal Stents & Others), Disease Indication (Venous Disease, Arterial Disease), End User and Regional Forecast, 2020 - 2029 (Includes COVID-19 Business Impact)

                                          
We have updated Cardiovascular Stents Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Cardiovascular Stents market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Cardiovascular Stents market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Cardiovascular Stents Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Cardiovascular Stents Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Cardiovascular Stents Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

  
Biotronik SE & Co. KG
  
Cardinal Health
  
Cook
  
C. R. Bard, Inc.
  
MicroPort Scientific Corporation
  
Terumo Corporation
  
B. Braun Melsungen AG
  
Abbott
  
Boston Scientific Corporation
  
Medtronic
  
Other players

REPORT OVERVIEW

Recent advancements in cardiac care are increasing awareness about cardiovascular diseases across the globe. The advancements in the percutaneous coronary interventions are improving the operational capabilities and reducing errors. The efficiency of stent placements is being enhanced owing to the availability of well-qualified interventional cardiologists across the globe.

he report provides qualitative and quantitative insights on the cardiovascular stents industry and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented on the basis of procedure type, stent type, disease indication, and end-user. On the basis of procedure type, the cardiovascular stents market is categorized into coronary stenting & peripheral stenting. Various stent types covered in the report are drug-eluting stents (DES), bioresorbable stents, bare-metal stents, and others. In terms of disease indication, the market is categorized into venous diseases & arterial diseases, while various end-users in the report are hospitals, ambulatory surgery centers, specialty clinics, and catheterization labs. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further categorized into countries.

Along with this, the report provides an elaborative analysis of the cardiovascular stents market value dynamics and competitive landscape. Various key insights provided in the report are the prevalence of key cardiovascular diseases (Peripheral Artery Diseases & Coronary Artery Diseases) by major countries, pricing analysis, recent industry developments such as partnerships, mergers & acquisitions, a regulatory scenario for key countries, and health reimbursement scenario for key countries.

Segmentation

By Product Type

  
Coronary Stenting
  
Peripheral Stenting

By Stent Type

  
Drug Eluting Stents (DES)
  
Bioresorbable Stents
  
Bare Metal Stents
  
Others

By Disease Indication

  
Venous Disease
  
Arterial Disease

By End User

  
Hospitals
  
Ambulatory Surgery Centers
  
Specialty Clinics
  
Catheterization Labs

By Geography

  
North America (USA and Canada)
  
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Key Industry Developments

In February 2018, Medtronic announced the FDA approval and launch of Resolute Onyx 2.0 mm Drug-Eluting Stent (DES), which the smallest size Drug-Eluting Stent (DES) available in the market.

In October 2017, Abbott received CE approval for XIENCE Sierra, an everolimus-eluting coronary stent system for sale in all the CE mark countries

In July 2016, Abbott received FDA approval for Absorb GT1 BVS, an absorbable stent for the treatment of coronary artery disease.